Smith & Nephew PLC
SNN33.420USD
+0.540+1.64%
Close 11/25, 16:00（ET）Quotes delayed by 15 min
14.64BMarket Cap
--P/E TTM
More Details of Smith & Nephew PLC Company
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Smith & Nephew PLC Info
Ticker SymbolSNN
Company nameSmith & Nephew PLC
IPO dateAug 13, 1951
CEOMr. Deepak S. Nath
Number of employees17349
Security typeEquity Future
Fiscal year-endAug 13
AddressBuilding 5
CityWATFORD
Stock exchangeJohannesburg Stock Exchange
CountryUnited Kingdom
Postal codeWD18 8YE
Phone4401923477100
Websitehttps://www.smith-nephew.com/
Ticker SymbolSNN
IPO dateAug 13, 1951
CEOMr. Deepak S. Nath
Company Executives of Smith & Nephew PLC
Name
Name/Position
Position
Shareholding
Change
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.35K
+1.08%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+28.58%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.27K
+0.95%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.14K
+2.62%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Other
1.90B
32.62%
By RegionUSD
Name
Revenue
Proportion
United States of America
3.12B
53.75%
Other Established Markets
1.27B
21.88%
Emerging &internatiuonal market
980.00M
16.87%
United Kingdom
226.00M
3.89%
China
210.00M
3.61%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Other
1.90B
32.62%
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
Other
97.55%
Shareholders
Shareholders
Proportion
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
Other
97.55%
Shareholder Types
Shareholders
Proportion
Investment Advisor
3.65%
Research Firm
2.01%
Investment Advisor/Hedge Fund
1.51%
Hedge Fund
0.27%
Family Office
0.17%
Family Office
0.17%
Pension Fund
0.15%
Family Office
0.12%
Individual Investor
0.01%
Other
91.94%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
458
32.77M
7.72%
-12.10M
2025Q2
468
34.86M
7.96%
-12.17M
2025Q1
470
32.31M
7.38%
-15.13M
2024Q4
454
34.98M
8.00%
-9.87M
2024Q3
442
33.73M
7.72%
-17.08M
2024Q2
451
37.69M
8.62%
-9.14M
2024Q1
460
34.95M
7.99%
-8.57M
2023Q4
456
32.65M
7.47%
-10.09M
2023Q3
451
40.30M
9.23%
-2.29M
2023Q2
453
39.60M
9.07%
-7.09M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BMO Capital Markets (US)
3.20M
0.75%
+2.62M
+455.42%
Jun 30, 2025
River Road Asset Management, LLC
3.18M
0.75%
+270.48K
+9.30%
Jun 30, 2025
Scharf Investments, LLC
2.08M
0.49%
+6.99K
+0.34%
Jun 30, 2025
Brandes Investment Partners, L.P.
1.60M
0.38%
+63.78K
+4.14%
Jun 30, 2025
Optiver Holding B.V.
1.15M
0.27%
+1.01M
+714.32%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
1.08M
0.25%
-18.79K
-1.72%
Jun 30, 2025
Parametric Portfolio Associates LLC
971.46K
0.23%
-1.36K
-0.14%
Jun 30, 2025
BNP Paribas Securities Corp. North America
644.52K
0.15%
+505.93K
+365.06%
Jun 30, 2025
Morgan Stanley & Co. LLC
823.55K
0.19%
+676.68K
+460.75%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
Brandes International ETF
1.21%
ALPS Disruptive Technologies ETF
0.94%
ActivePassive International Equity ETF
0.21%
SP Funds S&P World (ex-US) ETF
0.1%
Avantis Responsible International Equity ETF
0.08%
Avantis International Equity ETF
0.06%
DFA Dimensional International Core Equity 2 ETF
0.04%
SPDR S&P Kensho New Economies Composite ETF
0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
SGI Enhanced Global Income ETF
0%
Brandes International ETF
Proportion1.21%
ALPS Disruptive Technologies ETF
Proportion0.94%
ActivePassive International Equity ETF
Proportion0.21%
SP Funds S&P World (ex-US) ETF
Proportion0.1%
Avantis Responsible International Equity ETF
Proportion0.08%
Avantis International Equity ETF
Proportion0.06%
DFA Dimensional International Core Equity 2 ETF
Proportion0.04%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
Proportion0%
SGI Enhanced Global Income ETF
Proportion0%
Dividend
A total of
1.64B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 26, 2025
SNN.NB Approximate interim Cash Dividend of gross USD 0.462 paid on May 28, 2025 going ex on Mar 28, 2025
Mar 28, 2025
May 28, 2025
Mar 28, 2025
Sep 24, 2024
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 08, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Nov 08, 2024
Oct 04, 2024
Mar 04, 2024
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 22, 2024 going ex on Apr 01, 2024
Apr 02, 2024
May 22, 2024
Apr 01, 2024
Aug 03, 2023
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 01, 2023 going ex on Oct 05, 2023
Oct 06, 2023
Nov 01, 2023
Oct 05, 2023
Feb 27, 2023
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 17, 2023 going ex on Mar 30, 2023
Mar 31, 2023
May 17, 2023
Mar 30, 2023
Jul 29, 2022
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 26, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 26, 2022
Sep 29, 2022
Mar 14, 2022
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 11, 2022 going ex on Mar 31, 2022
Apr 01, 2022
May 11, 2022
Mar 31, 2022
Aug 12, 2021
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 27, 2021 going ex on Sep 30, 2021
Oct 01, 2021
Oct 27, 2021
Sep 30, 2021
Feb 19, 2021
SNN.NB Final Cash Dividend of gross USD 0.462 paid on May 12, 2021 going ex on Apr 05, 2021
Apr 06, 2021
May 12, 2021
Apr 05, 2021
Jul 29, 2020
SNN.NB Interim Cash Dividend of gross USD 0.288 paid on Oct 28, 2020 going ex on Oct 01, 2020
Oct 02, 2020
Oct 28, 2020
Oct 01, 2020
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Smith & Nephew PLC?
The top five shareholders of Smith & Nephew PLC are:
BMO Capital Markets (US) holds 3.20M shares, accounting for 0.75% of the total shares.
River Road Asset Management, LLC holds 3.18M shares, accounting for 0.75% of the total shares.
Scharf Investments, LLC holds 2.08M shares, accounting for 0.49% of the total shares.
Brandes Investment Partners, L.P. holds 1.60M shares, accounting for 0.38% of the total shares.
Optiver Holding B.V. holds 1.15M shares, accounting for 0.27% of the total shares.
BMO Capital Markets (US) holds 3.20M shares, accounting for 0.75% of the total shares.
River Road Asset Management, LLC holds 3.18M shares, accounting for 0.75% of the total shares.
Scharf Investments, LLC holds 2.08M shares, accounting for 0.49% of the total shares.
Brandes Investment Partners, L.P. holds 1.60M shares, accounting for 0.38% of the total shares.
Optiver Holding B.V. holds 1.15M shares, accounting for 0.27% of the total shares.
What are the top three shareholder types of Smith & Nephew PLC?
The top three shareholder types of Smith & Nephew PLC are:
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC
How many institutions hold shares of Smith & Nephew PLC (SNN)?
As of 2025Q3, 458 institutions hold shares of Smith & Nephew PLC, with a combined market value of approximately 32.77M, accounting for 7.72% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -0.24%.
What is the biggest source of revenue for Smith & Nephew PLC?
In FY2024, the Sports Medicine Joint Repair business generated the highest revenue for Smith & Nephew PLC, amounting to 982.00M and accounting for 16.90% of total revenue.
